Sep 2, 2025, 08:47
SUGAR Trial in Heart BMJ: Stent Outcomes in Patients With Diabetes Under the Spotlight
Heart BMJ posted on X:
”SUGAR and stents: evaluating long-term percutaneous coronary intervention outcomes in patients with diabetes”
Read the full articlle here.
Diabetes makes coronary disease more severe, with narrower, calcified vessels.
Patients with diabetes face higher risks after PCI — heart attack, stent problems, repeat procedures, death.
Risks exist even in silent or pre-diabetes.
Drug-eluting stents improved outcomes but risk stays higher vs. non-diabetics.
The SUGAR trial tested new stents in diabetes — no clear winner yet, but key insights for care.
Stay updated with Haemostasis Today.
-
Nov 2, 2026, 10:30Asesa Omullo: Connecting Sickle Cell Advocates at GANSID 2026
-
Nov 2, 2026, 10:18Salih Ehsan: Beyond IRIDA – Conditions That Mimic Iron-Refractory Anemia
-
Nov 2, 2026, 10:03Christian Heiss: Can Switching to E-Cigarettes Improve Vascular Health?
-
Nov 2, 2026, 09:56Priya Prasad: Safe Blood Begins with Informed Choices
-
Nov 2, 2026, 09:43Moath Ahmad Albliwi: More Than 10 Abstracts Accepted for ASH 2026
-
Nov 2, 2026, 02:56Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells
-
Nov 2, 2026, 02:45Marija Tashkovska: Advancing Transfusion Medicine Through Collaboration
-
Nov 2, 2026, 02:32Rachel Rosovsky: Pulmonary Embolism During Pregnancy and Postpartum
-
Nov 2, 2026, 02:26Jaromir Vajter: Bleeding Risks and Anticoagulation After ECPR